tiprankstipranks
Lipocine (LPCN)
NASDAQ:LPCN

Lipocine Financial Statements

Lipocine Financial Overview

Lipocine's market cap is currently ―. The company's EPS TTM is $-0.01; its P/E ratio is -94.24; Lipocine is scheduled to report earnings on August 10, 2022, and the estimated EPS forecast is $-0.04. See an overview of income statement, balance sheet, and cash flow financials.
Mar 22Dec 21Sep 21Jun 21Mar 21
Income Statement
Total Revenue$ 0.00$ 16.09M$ 54.99K$ 0.00$ 0.00
Gross Profit$ ―$ 13.83M$ -2.31M$ -1.46M$ ―
EBIT$ -3.47M$ 12.66M$ -3.04M$ -6.75M$ -3.30M
EBITDA$ -3.47M$ 12.66M$ -3.04M$ -6.75M$ -3.30M
Net Income Common Stockholders$ -3.49M$ 12.62M$ -3.08M$ -6.81M$ -3.37M
Balance Sheet
Cash, Cash Equivalents and Short-Term Investments$ 18.80M$ 19.67M$ 38.66M$ 42.00M$ 44.62M
Total Assets$ 47.60M$ 52.48M$ 40.39M$ 47.18M$ 50.58M
Total Debt$ 2.92M$ 4.57M$ 6.29M$ 3.21M$ 3.33M
Net Debt$ -15.88M$ -15.10M$ -32.38M$ -38.79M$ -41.28M
Total Liabilities$ 5.19M$ 6.91M$ 7.58M$ 11.43M$ 8.19M
Stockholders Equity$ 14.51M$ 15.34M$ 32.81M$ 35.75M$ 42.39M
Cash Flow
Free Cash Flow$ -3.91M$ 8.99M$ -6.98M$ -2.36M$ -4.06M
Operating Cash Flow$ -3.89M$ 8.99M$ -6.98M$ -2.36M$ -4.06M
Investing Cash Flow$ 7.30M$ -9.72M$ 1.37M$ -1.43M$ -33.99M
Financing Cash Flow$ -627.35K$ -838.46K$ -838.26K$ -838.61K$ 29.44M
Currency in USD

Lipocine Earnings and Revenue History


Lipocine Debt to Assets


Lipocine Cash Flow


Lipocine Forecast EPS vs Actual EPS


What's Included in PREMIUM?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis